OptimizeRx Corporation
$7.2
0%
2026-04-21 08:39:02
www.optimizerx.com
NCM: OPRX
Explore OptimizeRx Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$134.53 M
Current Price
$7.2
52W High / Low
$22.25 / $5.54
Stock P/E
26.21
Book Value
$6.84
Dividend Yield
—
ROCE
7.75%
ROE
4.18%
Face Value
—
EPS
$0.27
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
132
Beta
1.28
Debt / Equity
20.35
Current Ratio
3.04
Quick Ratio
3.04
Forward P/E
5.4
Price / Sales
1.05
Enterprise Value
$117.75 M
EV / EBITDA
7.18
EV / Revenue
1.08
Rating
Strong Buy
Target Price
$14.5
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Certara, Inc. | $6.19 | — | $989.85 M | — | 1.5% | -0.15% | $15.38 / $5.19 | $6.68 |
| 2. | Spok Holdings, Inc. | $11.48 | 14.99 | $237.98 M | 10.89% | 12.85% | 10.55% | $19.31 / $10.81 | $7.1 |
| 3. | Mangoceuticals, Inc. | $0.51 | — | $7.43 M | — | -62.34% | -1.42% | $2.88 / $0.16 | $1.13 |
| 4. | VSee Health, Inc. | $0.24 | — | $11.87 M | — | -476.79% | -5.42% | $2.52 / $0.19 | $-0.33 |
| 5. | Omada Health, Inc. | $14.04 | — | $827.31 M | — | -5.21% | -8.68% | $28.4 / $10.28 | $3.93 |
| 6. | So-Young International Inc. | $2.9 | — | $283.61 M | 0% | -4.01% | -13.61% | $6.28 / $0.74 | $2.25 |
| 7. | LifeMD, Inc. | $5.06 | 15.69 | $242.75 M | 1.28% | -26.6% | -1.31% | $15.84 / $2.56 | $0.5 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 32.24 M | 26.07 M | 29.2 M | 21.93 M | 32.32 M | — |
| Operating Profit | 8.94 M | 2.05 M | 3.19 M | -2.11 M | 3.63 M | — |
| Net Profit | 5.02 M | 0.78 M | 1.53 M | -2.2 M | -0.08 M | — |
| EPS in Rs | 0.27 | 0.04 | 0.08 | -0.12 | -0 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 109.43 M | 92.13 M | 71.52 M | 62.45 M |
| Operating Profit | 12.06 M | -6.22 M | -17.52 M | -12.29 M |
| Net Profit | 5.13 M | -20.11 M | -17.57 M | -11.44 M |
| EPS in Rs | 0.27 | -1.07 | -0.94 | -0.61 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 176.92 M | 171.17 M | 183.37 M | 134.65 M |
| Total Liabilities | 48.62 M | 54.17 M | 56.82 M | 8.54 M |
| Equity | 128.29 M | 117 M | 126.55 M | 126.11 M |
| Current Assets | 64.72 M | 53.97 M | 54.33 M | 98.58 M |
| Current Liabilities | 21.26 M | 18.65 M | 17.88 M | 8.4 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 18.71 M | 4.89 M | -7.24 M | 10.65 M |
| Investing CF | 0.07 M | -0.45 M | -25.34 M | -58.18 M |
| Financing CF | -8.8 M | -4.91 M | 28.22 M | -18.95 M |
| Free CF | 18.71 M | 4.44 M | -8.11 M | 10.41 M |
| Capex | — | -0.45 M | -0.87 M | -0.24 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 28.81% | 14.53% | — | — |
| Earnings Growth % | -14.48% | -53.57% | — | — |
| Profit Margin % | -21.83% | -24.56% | -18.32% | — |
| Operating Margin % | -6.75% | -24.5% | -19.68% | — |
| Gross Margin % | 64.45% | 59.98% | 62.4% | — |
| EBITDA Margin % | -9.66% | -29.79% | -15.08% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.